AB-161

N/A

Report date: 2025/03/19 16:06:42
NME

Base Information

Drug NameAB-161
Drug Alias NameAB-161
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus inhibitorsTerminal nucleotidyltransferase 4A inhibitorsTerminal nucleotidyltransferase 4B inhibitors
TargetsViral RNAHepatitis B virusTerminal nucleotidyltransferase 4A +[4] 
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArbutus Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesArbutus Biopharma Corp
Inactive CompaniesArbutus Biopharma Inc
Active IndicationsHepatitis B, Chronic
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A